Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8932

1.

Third-line chemotherapy in advanced gastric cancer: A systematic review and meta-analysis.

Zheng Y, Zhu XQ, Ren XG.

Medicine (Baltimore). 2017 Jun;96(24):e6884. doi: 10.1097/MD.0000000000006884. Review.

2.

Gastric adenocarcinoma.

Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S.

Nat Rev Dis Primers. 2017 Jun 1;3:17036. doi: 10.1038/nrdp.2017.36. Review.

PMID:
28569272
3.

Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: A bibliometric analysis.

Miao Y, Liu R, Pu Y, Yin L.

Medicine (Baltimore). 2017 May;96(20):e6924. doi: 10.1097/MD.0000000000006924. Review.

4.

Future Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer.

Shah MA.

Hematol Oncol Clin North Am. 2017 Jun;31(3):545-552. doi: 10.1016/j.hoc.2017.01.010. Epub 2017 Mar 22. Review.

PMID:
28501093
5.

Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma.

Anandappa G, Chau I.

Hematol Oncol Clin North Am. 2017 Jun;31(3):529-544. doi: 10.1016/j.hoc.2017.02.001. Epub 2017 Mar 22. Review.

PMID:
28501092
6.

Update on Gastroesophageal Adenocarcinoma Targeted Therapies.

Maron SB, Catenacci DVT.

Hematol Oncol Clin North Am. 2017 Jun;31(3):511-527. doi: 10.1016/j.hoc.2017.01.009. Review.

PMID:
28501091
7.

Antiangiogenic Therapy in Gastroesophageal Cancer.

Jin Z, Yoon HH.

Hematol Oncol Clin North Am. 2017 Jun;31(3):499-510. doi: 10.1016/j.hoc.2017.01.008. Epub 2017 Mar 22. Review.

PMID:
28501090
8.

The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.

Murphy AG, Kelly RJ.

Hematol Oncol Clin North Am. 2017 Jun;31(3):485-498. doi: 10.1016/j.hoc.2017.01.007. Epub 2017 Mar 30. Review.

PMID:
28501089
9.

Management of Metastatic Gastric Cancer.

Obermannov√° R, Lordick F.

Hematol Oncol Clin North Am. 2017 Jun;31(3):469-483. doi: 10.1016/j.hoc.2017.01.006. Epub 2017 Mar 22. Review.

PMID:
28501088
10.

The Role of Radiotherapy in Localized Esophageal and Gastric Cancer.

Ng J, Lee P.

Hematol Oncol Clin North Am. 2017 Jun;31(3):453-468. doi: 10.1016/j.hoc.2017.01.005. Epub 2017 Mar 22. Review.

PMID:
28501087
11.

Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?

Al-Batran SE, Lorenzen S.

Hematol Oncol Clin North Am. 2017 Jun;31(3):441-452. doi: 10.1016/j.hoc.2017.01.004. Epub 2017 Mar 29. Review.

PMID:
28501086
12.

Staging in Esophageal and Gastric Cancers.

Hayes T, Smyth E, Riddell A, Allum W.

Hematol Oncol Clin North Am. 2017 Jun;31(3):427-440. doi: 10.1016/j.hoc.2017.02.002. Review.

PMID:
28501085
13.

The Gastric Microbiome and Its Influence on Gastric Carcinogenesis: Current Knowledge and Ongoing Research.

Zhang C, Powell SE, Betel D, Shah MA.

Hematol Oncol Clin North Am. 2017 Jun;31(3):389-408. doi: 10.1016/j.hoc.2017.01.002. Epub 2017 Mar 22. Review.

PMID:
28501083
14.

Epithelial-mesenchymal transition and gastric cancer stem cell.

Xia P, Xu XY.

Tumour Biol. 2017 May;39(5):1010428317698373. doi: 10.1177/1010428317698373. Review.

PMID:
28459211
15.

Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.

Girardi DM, Silva ACB, Rêgo JFM, Coudry RA, Riechelmann RP.

Cancer Treat Rev. 2017 May;56:28-35. doi: 10.1016/j.ctrv.2017.04.002. Epub 2017 Apr 17. Review.

PMID:
28456055
16.

Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis.

Zhang Z, Xin S, Gao M, Cai Y.

Medicine (Baltimore). 2017 Apr;96(17):e6708. doi: 10.1097/MD.0000000000006708. Review.

17.

Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks: A meta-analysis.

Li Q, Liu J, Gong Y, Yuan Y.

Medicine (Baltimore). 2017 Apr;96(17):e6620. doi: 10.1097/MD.0000000000006620. Review.

18.

Solitary Gastric Metastasis from a Stage IA Serous Ovarian Carcinoma: A Case Report with Literature Review.

Mizuguchi K, Minato H, Yoshida I, Iwadare J, Kayahashi K, Mitani Y, Watanabe K.

Intern Med. 2017;56(8):915-919. doi: 10.2169/internalmedicine.56.7784. Epub 2017 Apr 15. Review.

19.

Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.

Dai M, Yuan F, Fu C, Shen G, Hu S, Shen G.

PLoS One. 2017 Apr 12;12(4):e0175357. doi: 10.1371/journal.pone.0175357. eCollection 2017. Review.

20.

Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features.

Fang M, Tao Y, Liu Z, Huang H, Lao M, Huang L, Zhu B.

Biomed Res Int. 2017;2017:8047183. doi: 10.1155/2017/8047183. Epub 2017 Mar 16. Review.

Supplemental Content

Loading ...
Support Center